HOME >> BIOLOGY >> NEWS
Largest synthetic gene ever built offers insights into anti-malarial drug resistance

Washington, DC -- Researchers at Georgetown University Medical Center say they are moving closer to understanding why the most lethal form of human malaria has become resistant to drug treatment in the past three decades. They have been able to artificially construct, and then express in yeast, a protozoan gene that contributes to such resistance. And it was no small feat. The gene they laboriously constructed over a two-year period is believed to be the largest “synthetic” one ever built, and it successfully produces large quantities of the encoded protein, whose function can now be easily studied.

In research published in the May 22 issue of the journal Biochemistry, the researchers say that with the addition of the recreated gene, PfMDR1 and its protein, they have all the biomolecular tools necessary to molecularly understand how the malarial parasite Plasmodium falciparum (P. falciparum), has become resistant to most of the drugs that could once destroy it. They have already described and expressed two other genes known to confer drug resistance.

"Now that we have these genes expressed in a convenient yeast system, we can work to understand the molecular basis of anti-malarial drug resistance, providing insight into how future drugs might be designed to effectively kill the parasite," said Paul Roepe, Ph.D., a professor in the Department of Biochemistry and Cellular & Molecular Biology as well as the Department of Chemistry.

Any animal with red blood cells can develop malaria, which is caused by a single-cell protozoan parasite transmitted by the bite of the female Anopheles mosquito. There are about 160 different species of malaria parasites, according to Roepe. Five infect humans, but P. falciparum is responsible for about 1 million deaths out of 300 million acute cases of infection each year. Most of these deaths occur in young children living in sub-Saharan Africa.

Roepe and his collaborators at Georgetown Univers
'"/>

Contact: Laura Cavender
lsc6@georgetown.edu
202-687-5100
Georgetown University Medical Center
6-Jun-2007


Page: 1 2 3 4

Related biology news :

1. Largest ever study of genetics of common diseases published today
2. Largest physics meeting of the year, in Denver
3. Largest-ever search for autism genes reveals new clues
4. Largest genomic search finds genes that may contribute to autism
5. Largest study of human interactome reveals a novel way
6. Scientists call for global push to advance research in synthetic biology
7. New synthetic self-assembling macromolecules mimic nature
8. Williams College biologist explores photosynthetic apparatus
9. Scientists identify synthetic compound that keeps stem cells young
10. Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice
11. Early exposure to synthetic estrogen puts DES Daughters at higher risk for breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2019)... LOS ANGELES (PRWEB) , ... September 20, 2019 ... ... says that instrument makers are adjusting to client demands for precision medicine products. ... that with demand exceeding $19 billion in 2018, the pharma/bio sector is the ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... group of doctors, scientists and engineers from the Medical University of Warsaw, met ... of their work to-date in creating a neuroprosthetic system as part of an ...
(Date:9/14/2019)... ... September 12, 2019 , ... Catalent, ... drugs, biologics, gene therapies, and consumer health products, today announced that professor David ... Dr. Schaffer has played an integral advisory role on the gene therapy industry, ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester Minnesota ... that the U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) ... recommendations for hypertension treatment. , The patent applies to Geneticure’s first pharmacogenomics ...
(Date:9/17/2019)... JUPITER, Fla. (PRWEB) , ... September 16, 2019 ... ... will broadcast Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local ... Credo Biomedical Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore ...
(Date:9/11/2019)... ... September 09, 2019 , ... ... trial randomization and drug supply chain management, today announced its new technology partnership ... sciences industry. , “The integration between Veeva Vault EDC and our IRT will ...
(Date:9/9/2019)... (PRWEB) , ... September 09, 2019 , ... Visikol CEO ... that was focused on how best to characterize 3D cell culture models. The ... that they are too thick and opaque to image through and therefore traditional wide-field ...
Breaking Biology Technology:
Cached News: